Hershey tops estimates as GLP‑1 users drive demand for mints, healthier snacks

Hershey beat Q1 estimates with net sales of $3.10 billion versus $3.03 billion expected and adjusted EPS of $2.35 versus $2.04 consensus. Demand for healthier snacks and functional snacking products helped offset weakness in confectionery, with Ice Breakers retail sales up 8% and North America salty snack organic volumes up 5% on LesserEvil. Management reiterated full-year sales and profit targets, though it flagged a likely deceleration in the remainder of the year.

Analysis

The key signal is not that HSY beat, but that mix is shifting toward higher-margin, function-led products while the traditional confectionery core is still soft. That creates a near-term earnings quality upgrade: less dependence on promo-heavy candy demand and more on niche products with better pricing power and lower elasticity. The second-order effect is that Hershey may be able to defend margin even if top-line growth slows, which matters more than the headline EPS beat in a consumer tape where volume is getting harder to manufacture.

The bigger competitive implication is that GLP-1-driven behavior change is redistributing basket share away from impulse candy toward “need-state” snacks, mints, and portion-controlled products. That helps branded incumbents with shelf space and innovation budgets, but it pressures smaller confectionery names and private-label snacks that lack credibility in wellness-adjacent segments. It also increases the value of product development speed and acquisition optionality: the winners will be the companies that can repurpose existing distribution into functional formats before the cycle normalizes.

The market may be underestimating the duration risk. Right now this looks like a multi-quarter tailwind, but if the GLP-1 adoption curve pauses, insurer coverage tightens, or consumers adapt behavior around side effects, the demand lift can fade quickly. More importantly, Hershey’s own guide implies a tougher back half, so the stock is exposed to a classic disappointment setup if investors extrapolate the current mix benefit into 2026 rather than treating it as a bridge.

Contrarian view: the best trade may not be long HSY outright, but long the companies that can monetize the same shift with less earnings dependency on legacy candy. If functional snacking remains sticky, the category expansion could be larger than Hershey’s current penetration suggests; if it reverses, HSY still has a defensive baseline, whereas smaller “healthier snack” names may not. The asymmetry is therefore better expressed through relative value than a simple directional long.

Key Decisions for Investors

• Long HSY vs. a basket of traditional confectionery/impulse names over the next 1-3 months; use the pair to isolate functional-snacking share gain from category weakness. Risk/reward favors the long side if investors continue to rotate toward defensive consumer names, but trim if volume comps reaccelerate in candy by mid-year.
• Buy HSY 3-6 month call spreads after any post-earnings consolidation. The setup is for modest upside re-rating, not a breakout; defined risk fits a thesis that the stock can grind higher as margin quality improves, while guidance caution caps multiple expansion.
• Short a basket of smaller snack or confectionery companies with weaker wellness positioning against HSY for 2-4 quarters. The second-order risk is shelf-space loss and lower innovation velocity as retail buyers favor brands that can credibly serve GLP-1 consumers.
• For investors wanting direct GLP-1 exposure, prefer a basket trade in healthcare/obesity beneficiaries over chasing consumer-packaged goods names. The consumer side is a slower, more uncertain monetization path, so the cleaner trade is to own the drug enablers rather than the downstream effect.
• If HSY rallies sharply on ‘functional snacking’ headlines, fade strength via a short-dated call overwrite or short-term put spread. The market may be over-discounting a durable step-up in growth when the company itself signals a second-half deceleration.